Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel disease.
McShane C, Varley R, Fennessy A, Byron C, Campion JR, Hazel K, Costigan C, Ring E, Marrinan A, Judge C, Sugrue K, Cullen G, Dunne C, Hartery K, Iacucci M, Kelly O, Leyden J, McKiernan S, O'Toole A, Sheridan J, Slattery E, Boland K, McNamara D, Egan L, Ghosh S, Doherty G, McCarthy J, Kevans D. McShane C, et al. Among authors: doherty g. Dig Liver Dis. 2025 Jan;57(1):274-281. doi: 10.1016/j.dld.2024.08.055. Epub 2024 Sep 21. Dig Liver Dis. 2025. PMID: 39307602
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease.
Judge C, McGettigan N, Ryan T, Hazel K, Singh P, Parihar V, Stack R, O'Connor A, Dunne C, Cullen G, Egan L, Harewood G, MacCarthy F, McKiernan S, Mulcahy H, Murray F, Patchett S, Sheridan J, Cheriyan D, Farrell R, Keohane J, Kelly O, McNamara D, Ryan B, O'Morain C, Sengupta S, O'Toole A, Buckley M, McCarthy J, Doherty G, Kevans D, Slattery E. Judge C, et al. Among authors: doherty g. Scand J Gastroenterol. 2020 Jul;55(7):786-794. doi: 10.1080/00365521.2020.1779340. Epub 2020 Jun 16. Scand J Gastroenterol. 2020. PMID: 32544012
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis.
O'Connell J, Rowan C, Stack R, Harkin G, Parihar V, Chan G, Breslin N, Cullen G, Dunne C, Egan L, Harewood G, Leyden J, MacCarthy F, MacMathuna P, Mahmud N, McKiernan S, McNamara D, Mulcahy H, Murray F, O'Connor A, O'Toole A, Patchett S, Ryan B, Sheridan J, Slattery E, Doherty G, Kevans D. O'Connell J, et al. Among authors: doherty g. Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1019-1026. doi: 10.1097/MEG.0000000000001177. Eur J Gastroenterol Hepatol. 2018. PMID: 29878945
Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
Judge C, Saeidi R, Sugrue K, Rabbitt L, Keogh A, Byron C, Zulquernain SA, Gleeson S, O'Toole A, Buckley M, Slattery E, Doherty G, McCarthy J. Judge C, et al. Among authors: doherty g. Inflamm Bowel Dis. 2021 May 17;27(6):956-959. doi: 10.1093/ibd/izab028. Inflamm Bowel Dis. 2021. PMID: 33544119 No abstract available.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation.
Storan D, McDermott E, Moloney J, Keenan L, Stack R, Sheridan J, Doherty G, Cullen G, McHugh L, Mulcahy HE. Storan D, et al. Among authors: doherty g. Frontline Gastroenterol. 2023 Nov 10;15(2):130-136. doi: 10.1136/flgastro-2023-102428. eCollection 2024 Mar. Frontline Gastroenterol. 2023. PMID: 38486665 Free PMC article.
Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.
Clowry J, Sheridan J, Healy R, Deady S, Keegan D, Byrne K, Cullen G, Mulcahy H, Comber H, Parnell AC, Doherty G, Lally A. Clowry J, et al. Among authors: doherty g. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):978-985. doi: 10.1111/jdv.14105. Epub 2017 Feb 17. J Eur Acad Dermatol Venereol. 2017. PMID: 28045204
The effect of sedation on EGD inspection time.
Storan D, Sheridan J, Cullen G, Mulcahy H, Doherty G. Storan D, et al. Among authors: doherty g. Gastrointest Endosc. 2021 Oct;94(4):875-876. doi: 10.1016/j.gie.2021.05.013. Gastrointest Endosc. 2021. PMID: 34530977 No abstract available.
610 results